Hebert A Vargas
Overview
Explore the profile of Hebert A Vargas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1109
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woo S, Becker A, Leithner D, Mayerhoefer M, Friedman K, Tong A, et al.
Eur Radiol
. 2025 Jan;
PMID: 39853335
Objectives: An increasing number of patients with prostate cancer (PCa) undergo assessment with magnetic resonance imaging (MRI) and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT). This offers comprehensive multimodality...
2.
Woo S, Becker A, Ghafoor S, Barbosa F, Arita Y, Vargas H
Radiol Bras
. 2024 Jul;
57:e20240013.
PMID: 38993954
Objective: To investigate clinical, pathology, and imaging findings associated with inguinal lymph node (LN) metastases in patients with prostate cancer (PCa). Materials And Methods: This was a retrospective single-center study...
3.
Lenis A, Ravichandran V, Brown S, Alam S, Katims A, Truong H, et al.
Clin Cancer Res
. 2024 Jul;
30(17):3894-3903.
PMID: 38949888
Purpose: Patients with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) and high tumor mutational burden (TMB-H) prostate cancers are candidates for pembrolizumab. We define the genomic features, clinical course, and response to immune...
4.
Woo S, Beier S, Tong A, Hindman N, Vargas H, Kang S
AJR Am J Roentgenol
. 2024 Jun;
223(3):e2431280.
PMID: 38899844
Uterine sarcomas are rare; however, they display imaging features that overlap those of leiomyomas. The potential for undetected uterine sarcomas is clinically relevant because minimally invasive treatment of leiomyomas may...
5.
Charbel C, Andrieu P, Soliman M, Woo S, Zheng J, Capanu M, et al.
Radiol Imaging Cancer
. 2024 Mar;
6(2):e230063.
PMID: 38456787
Purpose To investigate the prevalence of , and mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these...
6.
Panebianco V, Briganti A, Boellaard T, Catto J, Comperat E, Efstathiou J, et al.
Nat Rev Urol
. 2023 Nov;
21(4):243-251.
PMID: 38036666
Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive...
7.
Soliman M, Kim T, Cheng M, McKenney A, Fassia M, Lamparello N, et al.
Radiol Imaging Cancer
. 2023 Nov;
5(6):e230176.
PMID: 37975804
No abstract available.
8.
Woo S, Becker A, Das J, Ghafoor S, Arita Y, Benfante N, et al.
Cancer Imaging
. 2023 Nov;
23(1):110.
PMID: 37964386
Background: Neoadjuvant chemotherapy (NAC) before radical cystectomy is standard of care in patients with muscle-invasive bladder cancer (MIBC). Response assessment after NAC is important but suboptimal using CT. We assessed...
9.
Wong B, Andrieu P, Sonoda Y, Chi D, Aviki E, Vargas H, et al.
Eur J Radiol
. 2023 Oct;
168:111122.
PMID: 37806193
Purpose: Ovarian-Adnexal Reporting and Data System (O-RADS) MRI uses a 5-point scale to establish malignancy risk in sonographically-indeterminate adnexal masses. The management of O-RADS MRI score 4 lesions is challenging,...
10.
Woo S, Andrieu P, Abu-Rustum N, Broach V, Zivanovic O, Sonoda Y, et al.
Acad Radiol
. 2023 Sep;
31(4):1388-1397.
PMID: 37661555
Rationale And Objectives: This study aimed to evaluate whether implementing structured reporting based on Ovarian-Adnexal Reporting and Data System (O-RADS) magnetic resonance imaging (MRI) in women with sonographically indeterminate adnexal...